Logo image of KAVL

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

NASDAQ:KAVL - Nasdaq - US4831044023 - Common Stock - Currency: USD

0.4856  +0.01 (+1.8%)

After market: 0.4557 -0.03 (-6.16%)

Fundamental Rating

2

Taking everything into account, KAVL scores 2 out of 10 in our fundamental rating. KAVL was compared to 20 industry peers in the Distributors industry. The financial health of KAVL is average, but there are quite some concerns on its profitability. KAVL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

KAVL had negative earnings in the past year.
KAVL had a negative operating cash flow in the past year.
KAVL had negative earnings in 4 of the past 5 years.
In the past 5 years KAVL reported 4 times negative operating cash flow.
KAVL Yearly Net Income VS EBIT VS OCF VS FCFKAVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

KAVL's Return On Assets of -75.84% is on the low side compared to the rest of the industry. KAVL is outperformed by 80.00% of its industry peers.
Looking at the Return On Equity, with a value of -87.15%, KAVL is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
ROA -75.84%
ROE -87.15%
ROIC N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
KAVL Yearly ROA, ROE, ROICKAVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

KAVL's Gross Margin of 68.14% is amongst the best of the industry. KAVL outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of KAVL has grown nicely.
The Profit Margin and Operating Margin are not available for KAVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
KAVL Yearly Profit, Operating, Gross MarginsKAVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

5

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KAVL has been increased compared to 1 year ago.
The number of shares outstanding for KAVL has been increased compared to 5 years ago.
Compared to 1 year ago, KAVL has an improved debt to assets ratio.
KAVL Yearly Shares OutstandingKAVL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
KAVL Yearly Total Debt VS Total AssetsKAVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

KAVL has an Altman-Z score of -4.86. This is a bad value and indicates that KAVL is not financially healthy and even has some risk of bankruptcy.
KAVL has a Altman-Z score of -4.86. This is in the lower half of the industry: KAVL underperforms 75.00% of its industry peers.
KAVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.86
ROIC/WACCN/A
WACC15.4%
KAVL Yearly LT Debt VS Equity VS FCFKAVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.88 indicates that KAVL should not have too much problems paying its short term obligations.
KAVL's Current ratio of 1.88 is in line compared to the rest of the industry. KAVL outperforms 60.00% of its industry peers.
KAVL has a Quick Ratio of 1.88. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
KAVL's Quick ratio of 1.88 is fine compared to the rest of the industry. KAVL outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
KAVL Yearly Current Assets VS Current LiabilitesKAVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

KAVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.20%, which is quite impressive.
Looking at the last year, KAVL shows a very negative growth in Revenue. The Revenue has decreased by -86.91% in the last year.
KAVL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -51.07% yearly.
EPS 1Y (TTM)58.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.92%
Revenue 1Y (TTM)-86.91%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-97.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KAVL Yearly Revenue VS EstimatesKAVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
KAVL Yearly EPS VS EstimatesKAVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -2 -4 -6 -8

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KAVL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KAVL Price Earnings VS Forward Price EarningsKAVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KAVL Per share dataKAVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KAVL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (8/5/2025, 8:00:02 PM)

After market: 0.4557 -0.03 (-6.16%)

0.4856

+0.01 (+1.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)06-16 2025-06-16
Earnings (Next)09-18 2025-09-18
Inst Owners1.63%
Inst Owner Change0%
Ins Owners20.19%
Ins Owner Change0%
Market Cap5.60M
Analysts82.86
Price TargetN/A
Short Float %10.36%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.3
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 15.87
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.15
BVpS0.92
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.84%
ROE -87.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.14%
FCFM N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z -4.86
F-Score4
WACC15.4%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-86.91%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-97.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.5%
OCF growth 3YN/A
OCF growth 5YN/A